Corporate Banner
Satellite Banner
Biomolecular Screening
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

IMAPAC Brings Together Blood Plasma Community

Published: Wednesday, July 17, 2013
Last Updated: Wednesday, July 17, 2013
Bookmark and Share
Upcoming Bioplasma gathering organized by IMAPAC to help facilitate the growth and innovation of quality plasma products in Asia.

Recognizing the region’s need to work towards self-sufficiency in plasma products, Bioplasma World Asia 2013 will bring together, for the second consecutive year, the Asian and international blood plasma community on 03-04 September 2013 at the Grand Hyatt, Bali. Plasma fractionators, blood centers, health authorities and other industry stakeholders will converge at this much awaited gathering to discuss strategic issues and explore opportunities within Asia-Pacific’s plasma therapeutics sector.

Asia faces a shortage in plasma and plasma products, with only 20% of the total world volume being fractionated here, despite comprising 60% of the world’s population. Several factors come into play, such as insufficient funding and a weak blood collection infrastructure. However, Asian countries have begun to make efforts in strengthening their capacity for plasma fractionation, and developments are underway.

Bioplasma World Asia 2013’s distinguished panel of speakers will share information and debate issues relating to the Asian plasma landscape, regulatory landscape, business strategies, market trends, and partnership opportunities to facilitate the development of the region’s plasma industry. Supported by the PPTA (Plasma Protein Therapeutics Association) and IPFA (International Plasma Fractionation Association), this event will be co-located with Asia’s first ever Bloodborne Pathogen Safety Workshop – a unique gathering bringing together regional and international stakeholders in the blood collection and transfusion sector to help safeguard the quality of collected blood.

Key speaking faculty for the Bioplasma 2013 event includes:
•    Dr. Russell Basser, Senior Vice President of Global Clinical Research & Development, CSL Benring, USA
•    Mr. Jan M. Bult, President and CEO, Plasma Protein Therapeutics Association (PPTA), USA
•    Pan Ruo-Wen, Senior Vice President, Hualan Biologicals, China
•    Dr. Ranjit S. Ajmani, Chief Executive Officer, PlasmaGen BioSciences, Bangalore, India
•    Kim Young-ho, Managing Director, Overseas Business Division, Green Cross Corporation, Korea
•    Dr. Thierry Burnouf, Professor, Taipei Medical University, Taiwan
•    Jan Over, Strategic Affairs, Sanquin Plasma Products, The Netherlands
•    Dr. Wolfgang Teschner, Director of Plasma Product Developmet/Product Support Department, Baxter, Austria
•    Mr. Theo Evers, Senior Advisor, International Plasma Fractionation Association (IPFA), Amsterdam, Netherlands
•    Stephanie Gunn, Deputy General Manager, National Blood Authority, Australia
•    Dr. Yuyun SM Soerdarmono, Director of Central Blood Center, Indonesian Red Cross, Indonesia
•    Dr. Chandra Viswanathan, Senior Vice President, Reliance Life Sciences, India
•    Dr. Chris Shue, President and CEO, Shanghai Syndegen Biopharmaceutical Company, China
•    Dr. Pierre-François Falcou, Alliances Director, LFB Biomedicaments, France
•    Dr. Surinder Singh, Director, National Institute of Biologicals, India
•    Johan Prevot, Executive Director, International Patient Organisation for Primary Immunodeficiencies (IPOPI), Portugal
•    Eric Youssef, European Plasma Market Director, Merck Millipore
•    Jerry A. Holmberg, Director, Scientific Affairs, Novartis Vaccines and Diagnostics, Inc.

Here are some brief testimonials from the attendees of last year’s event: “Very informative and helpful for me to understand the overview of plasma product in Asia!” - Hua Zhang, Chief GMP Inspection, CCE, ShFDA, China. “Good start! Looking forward to return!” - K Y Tan, General Manager, Haemonetics, Hong Kong. “Excellent content and great information on plasma products!” - Sunil Saigal, Director, Consolidated Products, India.


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,000+ scientific posters on ePosters
  • More than 4,400+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

SE Asia Government Leaders to Discuss Move Towards Self-Sufficiency in Plasma Fractionation
Self-sufficiency is important to reduce costs, prevent blood shortages and meet the transfusion requirements of patients.
Thursday, August 29, 2013
Scientific News
MicroRNA Pathway Could Lead to New Avenues for Leukemia Treatment
Cancer researchers at the University of Cincinnati have found a particular signaling route in microRNA (miR-22) that could lead to targets for acute myeloid leukemia, the most common type of fast-growing cancer of the blood and bone marrow.
Soy Shows Promise as Natural Anti-Microbial Agent
Soy isoflavones and peptides may inhibit the growth of microbial pathogens that cause food-borne illnesses, according to a new study from University of Guelph researchers.
Doubling Down on Dengue
HMS researchers have discovered two ways a compound blocks dengue virus.
Soy Shows Promise as Natural Anti-Microbial Agent
Researchers from University of Guelph show that soy isoflavones and peptides could be used to reduce microbial contamination of food.
AstraZeneca to Sequence 2 Million Genomes in Search for New Drugs
Company launches integrated genomics approach which aims to transform drug discovery and development.
Unique Model for Studying ALS
Unique mouse model will allow researchers to better study the genetic origins and potential treatments of ALS.
Targeting an ‘Undruggable’ Cancer Gene
RAS genes are mutated in more than 30 percent of human cancers and represent one of the most sought-after cancer targets for drug developers.
Biomarkers for Profiling Prostate Cancer Patients
Exiqon A/S has announced the publication of validation of prognostic microRNA biomarkers for the aggressiveness of prostate cancer in independent cohorts.
Improving Engineered T-Cell Cancer Treatment
Purdue University researchers may have figured out a way to call off a cancer cell assassin that sometimes goes rogue and assign it a larger tumor-specific "hit list."
Micro Heart Muscle Created from Stem Cells
Researchers have designed a new way to create micro heart muscle from stem cells using a unique dog bone dish.
SELECTBIO

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,000+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,400+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!